FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206746152> ?p ?o ?g. }

• W3206746152 endingPage "827" @default.
• W3206746152 startingPage "819" @default.
• W3206746152 abstract "Immune checkpoint inhibitors (ICIs) are potent new cancer therapies but can cause serious immune-related adverse events. ICIs have contributed significantly to improved survival and thereby provide more opportunity for the development of local disease symptomatology requiring palliative radiation. Radiation therapy (RT) has also recently shown benefit in the oligometastatic setting. Data on the interaction and safety of concurrent ICIs and RT are limited.In this retrospective cohort study using a large medical claims database from 2010 to 2017, the need for corticosteroid therapy and the risk of hospitalization within 180 days of treatment with an ICI were determined for patients with a diagnosis of malignant melanoma or lung cancer. Patients were stratified by the use of RT within the 30 days before and after ICI therapy.In all, 2020 patients (218 with RT and 1802 without RT) met the inclusion criteria for prednisone analysis, whereas 3519 patients (361 with RT and 3158 without RT) met the inclusion criteria for all other analyses. In a univariable analysis, RT was not associated with the need for prednisone (relative risk [RR], 1.2; 95% confidence interval [CI], 0.8-1.9) or methylprednisolone (RR, 1.1; 95% CI, 0.7-2.0). When the end point was hospitalization, RT was significantly associated with hospitalization after ICI therapy for certain cancer/drug combinations (RR for lung cancer/programmed death 1 receptor inhibitors, 1.4; 95% CI, 1.2-1.6; P < .001; RR for melanoma/ipilimumab, 2.0; 95% CI, 1.0-3.5; P = .03).In patients treated with ICIs, receiving RT was not associated with a higher risk of requiring corticosteroid therapy in comparison with not receiving RT. However, RT was associated with a higher risk of hospitalization, although this finding may be a result of differences in the underlying patient illness severity or oncologic disease burden at the baseline.Data on the interaction of immunotherapy (immune checkpoint inhibitors) and radiation therapy and the safety of combining them are limited. Using a large database, this study has found that patients treated concurrently with immune checkpoint inhibitors and radiation therapy are not at increased risk for requiring corticosteroid therapy (which is used as a proxy for immune-related adverse events). However, concurrent therapy is associated with a higher risk of hospitalization, although this finding may be due to differences in the underlying patient illness severity (sicker patients may require both immunotherapy and radiation therapy)." @default.
• W3206746152 created "2021-10-25" @default.
• W3206746152 creator A5011992517 @default.
• W3206746152 creator A5022041820 @default.
• W3206746152 creator A5031229662 @default.
• W3206746152 creator A5055200350 @default.
• W3206746152 creator A5056109316 @default.
• W3206746152 creator A5073666794 @default.
• W3206746152 creator A5081969877 @default.
• W3206746152 date "2021-10-11" @default.
• W3206746152 modified "2023-10-16" @default.
• W3206746152 title "Risk of corticosteroid treatment and hospitalization after checkpoint inhibitor and radiation therapy in patients with cancer" @default.
• W3206746152 cites W1581492120 @default.
• W3206746152 cites W2031688279 @default.
• W3206746152 cites W2032166347 @default.
• W3206746152 cites W2070636593 @default.
• W3206746152 cites W2104347254 @default.
• W3206746152 cites W2108789863 @default.
• W3206746152 cites W2156353875 @default.
• W3206746152 cites W2166662937 @default.
• W3206746152 cites W2280306471 @default.
• W3206746152 cites W2314254896 @default.
• W3206746152 cites W2515622316 @default.
• W3206746152 cites W2527905628 @default.
• W3206746152 cites W2573323145 @default.
• W3206746152 cites W2738008461 @default.
• W3206746152 cites W2753065806 @default.
• W3206746152 cites W2756648224 @default.
• W3206746152 cites W2759495409 @default.
• W3206746152 cites W2761351587 @default.
• W3206746152 cites W2762777471 @default.
• W3206746152 cites W2775321189 @default.
• W3206746152 cites W2781991155 @default.
• W3206746152 cites W2782652081 @default.
• W3206746152 cites W2786816161 @default.
• W3206746152 cites W2787553571 @default.
• W3206746152 cites W2891939073 @default.
• W3206746152 cites W2898254759 @default.
• W3206746152 cites W2910245285 @default.
• W3206746152 cites W2946000707 @default.
• W3206746152 cites W2966509934 @default.
• W3206746152 cites W3020551799 @default.
• W3206746152 cites W3032651552 @default.
• W3206746152 doi "https://doi.org/10.1002/cncr.33975" @default.
• W3206746152 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34634130" @default.
• W3206746152 hasPublicationYear "2021" @default.
• W3206746152 type Work @default.
• W3206746152 sameAs 3206746152 @default.
• W3206746152 citedByCount "1" @default.
• W3206746152 countsByYear W32067461522022 @default.
• W3206746152 crossrefType "journal-article" @default.
• W3206746152 hasAuthorship W3206746152A5011992517 @default.
• W3206746152 hasAuthorship W3206746152A5022041820 @default.
• W3206746152 hasAuthorship W3206746152A5031229662 @default.
• W3206746152 hasAuthorship W3206746152A5055200350 @default.
• W3206746152 hasAuthorship W3206746152A5056109316 @default.
• W3206746152 hasAuthorship W3206746152A5073666794 @default.
• W3206746152 hasAuthorship W3206746152A5081969877 @default.
• W3206746152 hasBestOaLocation W32067461521 @default.
• W3206746152 hasConcept C121608353 @default.
• W3206746152 hasConcept C126322002 @default.
• W3206746152 hasConcept C143998085 @default.
• W3206746152 hasConcept C167135981 @default.
• W3206746152 hasConcept C197934379 @default.
• W3206746152 hasConcept C207103383 @default.
• W3206746152 hasConcept C2776256026 @default.
• W3206746152 hasConcept C2777701055 @default.
• W3206746152 hasConcept C2778715236 @default.
• W3206746152 hasConcept C2778720950 @default.
• W3206746152 hasConcept C2781433595 @default.
• W3206746152 hasConcept C44249647 @default.
• W3206746152 hasConcept C509974204 @default.
• W3206746152 hasConcept C71924100 @default.
• W3206746152 hasConcept C82789193 @default.
• W3206746152 hasConceptScore W3206746152C121608353 @default.
• W3206746152 hasConceptScore W3206746152C126322002 @default.
• W3206746152 hasConceptScore W3206746152C143998085 @default.
• W3206746152 hasConceptScore W3206746152C167135981 @default.
• W3206746152 hasConceptScore W3206746152C197934379 @default.
• W3206746152 hasConceptScore W3206746152C207103383 @default.
• W3206746152 hasConceptScore W3206746152C2776256026 @default.
• W3206746152 hasConceptScore W3206746152C2777701055 @default.
• W3206746152 hasConceptScore W3206746152C2778715236 @default.
• W3206746152 hasConceptScore W3206746152C2778720950 @default.
• W3206746152 hasConceptScore W3206746152C2781433595 @default.
• W3206746152 hasConceptScore W3206746152C44249647 @default.
• W3206746152 hasConceptScore W3206746152C509974204 @default.
• W3206746152 hasConceptScore W3206746152C71924100 @default.
• W3206746152 hasConceptScore W3206746152C82789193 @default.
• W3206746152 hasFunder F4320337357 @default.
• W3206746152 hasIssue "4" @default.
• W3206746152 hasLocation W32067461521 @default.
• W3206746152 hasLocation W32067461522 @default.
• W3206746152 hasOpenAccess W3206746152 @default.
• W3206746152 hasPrimaryLocation W32067461521 @default.
• W3206746152 hasRelatedWork W1995278898 @default.
• W3206746152 hasRelatedWork W2104387234 @default.
• W3206746152 hasRelatedWork W2340130805 @default.

• next